Fan Yan-Ying, Hu Wei-Wei, Nan Fang, Chen Zhong
Department of Pharmacology, Shanxi Medical University, Taiyuan, 030001, China; Department of Pharmacology, Key Laboratory of Medical Neurobiology of the Ministry of Health of China, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China.
Department of Pharmacology, Key Laboratory of Medical Neurobiology of the Ministry of Health of China, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China.
Neurochem Int. 2017 Jul;107:43-56. doi: 10.1016/j.neuint.2017.01.006. Epub 2017 Jan 11.
Ischemic postconditioning (PostC) is defined as a series of rapid intermittent interruptions of blood flow at the phase of reperfusion, which produces neuroprotection against cerebral ischemia/reperfusion injury via mobilizing the brain's own endogenous adaptive mechanisms. Now the concept of conventional ischemic PostC has been extended to limb remote ischemic PostC and chemical PostC with hypoxia, volatile anesthetic, CO, etc. According to the different temporal profile of PostC, it is divided into rapid and delayed PostC. Rapid PostC is applied within a few seconds to minutes after reperfusion, while delayed PostC is applied at a few hours to days after reperfusion. Although the neuroprotective mechanisms of PostC are not completely elucidated, a series of mechanisms have been found to connect with PostC in the central nervous system, such as regulating synaptic signaling, attenuating oxidative stress and inflammation, maintaining mitochondrial integrity, inhibiting endoplasmic reticulum stress, regulating autophagy, activating PI3K/Akt pathway, inhibiting apoptosis, protecting neurovascular unit, etc. Based on these multiple protective mechanisms, PostC has high expectations to translate to the clinic, but a few issues should be resolved such as the time window, risks, efficiency, the impact of age, gender, hypertension, hyperlipidemia and t-PA, and clinical maneuverability. Even so, PostC could soon be at the bedside if the clinical trials are carefully planned.
缺血后适应(PostC)被定义为在再灌注阶段一系列快速间歇性血流中断,其通过调动大脑自身的内源性适应性机制对脑缺血/再灌注损伤产生神经保护作用。现在,传统缺血后适应的概念已扩展到肢体远程缺血后适应以及使用缺氧、挥发性麻醉剂、一氧化碳等的化学后适应。根据后适应的不同时间模式,可分为快速后适应和延迟后适应。快速后适应在再灌注后几秒到几分钟内应用,而延迟后适应在再灌注后几小时到几天应用。尽管后适应的神经保护机制尚未完全阐明,但已发现一系列机制在中枢神经系统中与后适应相关,如调节突触信号传导、减轻氧化应激和炎症、维持线粒体完整性、抑制内质网应激、调节自噬、激活PI3K/Akt通路、抑制细胞凋亡、保护神经血管单元等。基于这些多种保护机制,后适应在转化为临床应用方面寄予厚望,但仍有一些问题需要解决,如时间窗、风险、效率、年龄、性别、高血压、高脂血症和组织型纤溶酶原激活剂(t-PA)的影响以及临床可操作性等。即便如此,如果临床试验精心设计,后适应很快就能应用于临床。